2006-August Archives by Author

• Messages sorted by: [ thread ] [ subject ] [ date ]
• More info on this list...

Starting: Tue Aug 1 13:43:02 2006
Ending: Thu Aug 31 20:32:15 2006
Messages: 71

• [Ip-health] MSF report on WTO August 30th Decision and Canadian legislation   James ARKINSTALL
• [Ip-health] FTA Moratorium   B.Baker@neu.edu
• [Ip-health] Wall Street Journal: Gates, Clinton See AIDS Care-Delivery as Hurdle   Thiru Balasubramaniam
• [Ip-health] Kaisernetwork.org: WHO Gives Endorsement to Canadian Company's Combination HIV/AIDS Drug   Thiru Balasubramaniam
• [Ip-health] Nathan Ford in the Bangkok Post: Compulsory licensing seen crucial for treatment   Thiru Balasubramaniam
• [Ip-health] New York Times: A Generic Drug Tale, With an Ending Yet to Be Written   Thiru Balasubramaniam
• [Ip-health] The Hindu: Failed WTO talks: impact on TRIPS   Thiru Balasubramaniam
• [Ip-health] Financial Times: Patent or patient? How Washington uses trade deals to protect drugs   Thiru Balasubramaniam
• [Ip-health] Financial Times: Frontrunner to head WHO outlines reform   Thiru Balasubramaniam
• [Ip-health] The Scientist (25 July 2006): Hunt for new WHO head heats up   Thiru Balasubramaniam
• [Ip-health] Turkish Weekly: Turkey nominates Turmen for WHO's next director-general   Thiru Balasubramaniam
• [Ip-health] Bloomberg (July 25): WHO's Margaret Chan Nominated by China to Head UN Health Agency   Thiru Balasubramaniam
• [Ip-health] New York Times: U.S. Pushing for Release of Flu Data   Thiru Balasubramaniam
• [Ip-health] AP: CDC Releasing Gene Blueprints   Thiru Balasubramaniam
• [Ip-health] La Nacion: Bolivia, Brasil y Chile apoyan candidatura de Alfredo Palacio a OMS   Thiru Balasubramaniam
• [Ip-health] People's Daily Online (xinhua): Bolivia y Brasil apoyan candidatura Palacio a OMS   Thiru Balasubramaniam
• [Ip-health] New York Times: Clinton makes up for lost time in battling AIDS   Thiru Balasubramaniam
• [Ip-health] Financial Times: Cut-price HIV drugs drive may spur patents clash   Thiru Balasubramaniam
• [Ip-health] IP-Watch: Nine Candidates Proposed For WHO Director General Position   Thiru Balasubramaniam
• [Ip-health] job opening - IP Programme Officer - ICTSD   Johanna von Braun
• [Ip-health] The economics of mass HIV retroviral treatment]   Michelle Childs
• [Ip-health] BBC Video/Audio: 'Double Bill' on Aids issue]   Michelle Childs
• [Ip-health] Removing taxes and tariffs on essential medicines   Philip Coticelli
• [Ip-health] 9th edition of Untangling the Web   Celine DERCHE
• [Ip-health] 9th edition of Untangling the Web - revised   Celine DERCHE
• [Ip-health] Size of trials by status (S or P) - Some 2004 FDA and Parexcel data compared   Joseph DiMasi
• [Ip-health] Size of trials by status (S or P) - Some 2004 FDA and Parexcel data compared   Joseph DiMasi
• [Ip-health] Size of trials by status (S or P) - Some 2004 FDA and Parexcel data compared   Joseph DiMasi
• [Ip-health] FOUR STEPS FOR CANADA +++ QUATRE ACTIONS POUR LE CANADA   Richard Elliott
• [Ip-health] MSF at the Toronto International AIDS Conference   Kate Evans
• [Ip-health] Reminder - MSF Events at the Toronto International AIDS Conference   Kate Evans
• [Ip-health] FT: Poorer nations urged to push harder for cheaper aids drugs   Nathan Ford
• [Ip-health] FW: THAILAND: Trade deal could threaten HIV/AIDS treatments =?ISO-8859-1?B?liA=?=health experts   Nathan Ford
• [Ip-health] Lancet: The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic   Ira Glazer
• [Ip-health] new drug development blog post   Benjamin Krohmal
• [Ip-health] A compensatory model for data protection under consideration as most drugs face patent expiry   Gopa Kumar
• [Ip-health] Size of trials by status (S or P) - Some 2004 FDA and Parexcel data compared   James Love
• [Ip-health] Size of trials by status (S or P) - Some 2004 FDA and Parexcel data compared   James Love
• [Ip-health] Korean A-7 Prices Compared to U.S. Prices   James Love
• [Ip-health] SUNS: Growing Movement Opposing Granting of Drug Patents   Mike Palmedo
• [Ip-health] Court case in Argentina: Fraud by Novartis and Max Foundation targets patients   Joana Ramos
• [Ip-health] International AIDS Conference: NGO Brief on FTAs, IP and Access to Medicines   Sangeeta
• [Ip-health] Inside US trade: PHRMA opposes Pending Filipino Patent Law   Judit Rius Sanjuan
• [Ip-health] Financial Times editorials on FTAs   Judit Rius Sanjuan
• [Ip-health] Informal Lunch invitation   Dalindyebo Bafana Shabalala
• [Ip-health] Reuters, AFP, Nation on Thai protest against GSK patent app.   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] MSF: WHO sticks head in sand over high cost of newer AIDS drugs   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] Reuters: Pricing, lack of tools hamper child AIDS treatment   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] AFP: MSF demands action for half a million tragic AIDS infants   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] Globe and Mail: Canada's generic drug law is all talk, no action   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] Toronto Sun: Affordable drugs key to AIDS struggle   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] Toronto Star: Clement vows to get cheap drugs flowing   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] Bloomberg: AIDS Drugs, Prices Cut 90%, Out of Reach for Neediest   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] GlaxoSmithKline withdraws AIDS drug patent plan in Thailand, India   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] Bangkok Post: Glaxo axes bid to patent Aids drug   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] Globe & Mail: Drug access is critical, activists warn   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] Novartis challenges Indian patent law   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] The Lancet: Abbott accused of refusing access to HIV drug   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] Article on ARV production costs in AIDS Journal   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] WHO to help issue compulsory licenses   Khalil Elouardighi - Act Up-Paris
• [Ip-health] FT: Medicine and Markets   Stephanie Weinberg
• [Ip-health] South Africa's Treatment Action Campaign   julie.patel@cptech.org
• [Ip-health] Free Trade Agreements and Intellectual Property doom Access to Medicines   mkamalyanni@Oxfam.org.uk
• [Ip-health] Novartis challenges Indian Patent Law   msfh-india-medco-assist
• [Ip-health] SEMINAR ANNOUNCEMENT: The First South Innovation Perspectives Series seminar , 4 September 2006   musungu@southcentre.org
• [Ip-health] Korea unprepared for U.S. FTA talks   heeseob nam
• [Ip-health] Data Exclusivity-India   prabhu ram
• [Ip-health] =?iso-8859-1?Q?Invitation_to_MSF/Legal_Network_satellite_at_AIDS_2006_-_T?= =?iso-8859-1?Q?ue_Aug_15?=   relliott@aidslaw.ca
• [Ip-health] US Senators offer sweeping patent system changes   robert weissman
• [Ip-health] US says: U.S. and Korea Resolve Drug Dispute That Stalled Trade Talks   robert weissman
• [Ip-health] CEPR: MERCK, PFIZER, WYETH MAKING BILLIONS IN EXCESS PROFITS THROUGH MEDICARE DRUG PLAN   robert weissman

Last message date: Thu Aug 31 20:32:15 2006
Archived on: Thu Aug 31 19:32:16 2006

• Messages sorted by: [ thread ] [ subject ] [ date ]
• More info on this list...